Evidence map›Paper›PMID 41136688›Full record

Observational studyPediatric research2026

Pediatric respiratory co-infection and immunologic response: peds recon study protocol.

Milissa U Jones, Emily L Parsons, Priscilla A K Kobi, Alison M Helfrich, David King, David L Saunders, Allison M W Malloy

Abstract readObservational Study
In one paragraph

Observational study in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Milissa U JonesDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. milissa.jones@usuhs.edu.ORCID http://orcid.org/0009-0009-1798-2753
Emily L ParsonsDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Priscilla A K KobiThe Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA.
Alison M HelfrichDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
David KingThe Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA.
David L SaundersDepartment of Internal Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Allison M W MalloyDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute Viral Respiratory Infections (AVRIs) from SARS-CoV-2, influenza, and RSV are major causes of pediatric illness, yet little is known about how non-medically attended infections influence immune development. Understanding early-life AVRIs patterns and their impact on the developing mucosal immune system is essential to inform interventions that improve long-term child health.

methodsThis ongoing prospective observational cohort study, initiated in January 2024, investigates respiratory viral infections, co-infections, and their effects on immune responses in children aged 1 month to 17 years. Participants are followed for two years, with data collected at baseline (when healthy) and during acute visits (when symptomatic). At baseline, nasopharyngeal swabs and blood samples are collected for viral screening and immune analysis. During acute visits, swabs are collected for viral detection and immunologic assays. If SARS-CoV-2, influenza, or RSV is detected, a post-acute visit occurs 10-21 days after symptom onset for repeat swabs and blood collection. The primary outcome is to define age-based immune responses and assess how co-infections influence immune regulation. DISCUSSION: This study captures the full spectrum of pediatric AVRIs, including non-medically attended illnesses, to address gaps in immune development research. Findings may inform strategies to optimize prevention and treatment across childhood. IMPACT: Acute viral respiratory infections are the most common cause of childhood morbidity and mortality; however, they are frequently non-medically attended, leaving critical gaps in our understanding. Co-infections with respiratory viruses such as SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) may alter immune responses, but their impact on long-term immunity remains poorly understood. Understanding age-dependent patterns of respiratory viral infections and co-infections will provide critical insights into immune development and potential vulnerabilities in pediatric populations. This study aims to define age-based differences in immunity in the respiratory track in response to respiratory viral pathogens and examine the impact of co-infection on immune regulation.

Indexed as

CoinfectionCOVID-19Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsAdolescentChildChild, PreschoolFemaleHumansInfantMaleProspective StudiesSARS-CoV-2

Identifiers

PMID41136688
PMCPMC13433244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.